News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Akhil Santhosh: Switching 5 FU for docetaxel in the Tp-EXTREME trial
Jan 6, 2025, 11:11

Akhil Santhosh: Switching 5 FU for docetaxel in the Tp-EXTREME trial

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:

“Switching 5 FU for docetaxel in the Tp-EXTREME trial results in similar OS with a better safety profile.”

Akhil Santhosh

Akhil Santhosh cancer docetaxel MVR Cancer Centre OncoDaily Oncology Tp-EXTREME trial
Special Coverage
Blog
Jun 3, 2025, 08:32
Memorial Sloan Kettering Cancer Center - New Hope for People with Stomach and Esophagus Cancer
Blog
Jun 3, 2025, 08:19
Neeraj Agarwal Highlights Promising T-Cell Engager Data in Prostate Cancer at ASCO 2025
Blog
Jun 3, 2025, 08:06
Nazik Hammad Expresses Gratitude to Mentees After ASCO Award Recognition
Blog
Jun 3, 2025, 08:01
Pramesh CS: Patient-Centered and Globally Relevant Research at ASCO 2025
Blog
Jun 3, 2025, 07:55
Jasmine Kamboj: Fantastic Time at Dr Robin Zon’s Presidential Reception
Blog
Jun 3, 2025, 07:47
Brian Rini: ASCO25 Final Results of IO-based Combinations in mRCC are in
Blog
Jun 3, 2025, 07:43
CancerWorld is not about papers, it’s about people - Alberto Costa
Blog
Jun 3, 2025, 07:37
Sergio Cifuentes Reflects on Memorable Moments at ASCO 2025
Blog
Jun 3, 2025, 07:30
Aakash Desai: NSCLC Treatment Updates at ASCO 2025 Lung Cancer Session
Oncolibrary
Jun 3, 2025, 00:40
THE LEAP trial at ASCO 2025 : Lenvatinib+pembrolizumab and chemotherapy vs.chemotherapy in a/mGEA
Oncolibrary
Jun 3, 2025, 00:22
Trial Updates at ASCO 2025: Neoadjuvant Pembrolizumab, Dabrafenib, and Trametinib in BRAF V600E-Mutated ATC
Blog
Jun 2, 2025, 18:21
Richard Lee: SIO Team Presented Real-World Implementation of ASCO-SIO Guidelines at ASCO25